SPINAL ANAESTHESIA WITH 0.75 % BUPIVACAINE AND 0.5% AMETHOCAINE IN 5% GLUCOSE T. MARSTRAND, M. S0RENSEN AND S. ANDERSEN Amethocaine (usually with adrenaline) has been the standard agent for the provision of spinal anaesthesia in the United States and Europe although, during the past 6-7 yr, bupivacaine has been used for this purpose also (Nolte et al., 1977; Nightingale and Marstrand, 1981) . However, there are only a few studies in which bupivacaine and amethocaine have been compared in a controlled fashion in a relatively homogeneous group of patients (Ekblom and Widman, 1966; Pflug, Aasheim and Beck, 1976; Lanz, Schellenberg and Theiss, 1979; Moore, 1980) .
The present investigation compares a glucosefree solution of plain bupivacaine with the standard amethocaine solution (without vasopressor) in patients undergoing urological surgery. The solutions studied were 0.75% bupivacaine 3 ml and 0.5 % amethocaine 3 ml in 5 % glucose.
PATIENTS AND METHODS
Twenty patients (19 men) scheduled for urological surgery under spinal anaesthesia were included in the investigation (table I) , which was approved by the Regional Ethical Committee. Informed consent was obtained. The patients were randomly distributed into two groups. Age, weight, and height were comparable between the groups (table  II) .
In most patients premedication consisted of Lumbar puncture with a 25-gauge spinal needle using a standard midline approach with the patients in the lateral, horizontal decubitus position was performed via the L2-L3 or L4-L5 spaces. The spaces actually used were similar for both groups. One investigator administered the analgesia according to a randomized code, and another investigator evaluated the degree and extent of blockade.
Once a free flow of clear cerebrospinal fluid was obtained, 3 ml of either solution was injected (4-5 s ml" 1 ) without barbotage. Immediately after the injection the patient was turned supine and, 5 min later, was placed in the lithotomy position.
The cephalad spread of sensory analgesia (loss of the sensation of pin-prick) in the dependent and non-dependent sides was determined with the blunt end of a Sherwood B 400 27G/short needle at 2, 5, 10, 15, 20 and 30 min after injection, and then every 30 min.
Motor blockade in the dependent and nondependent sides was assessed by recording the degree of motor function in the lower limbs immediately following each determination of analgesia: 0 = no paralysis (full flexion of knees and feet); 1 = inability to raise extended leg (just able to move knees); 2 = inability to flex knees (able to move feet only); 3 = inability to flex ankle joint (unable to move feet or knees).
Note was made of the operating conditions and the need for additional medication.
The patient's progress was followed into the postoperative period for signs of postspinal complications.
Statistics
Differences between means were tested for significance by Student's t test and differences between proportions by Fisher's exact test. Significance: P < 0.05.
RESULTS

Surgery
Surgery was undertaken approximately 18 min after the injection and lasted for around 1 h (table III) .
Onset of sensory analgesia
The mean interval until the spread of sensory analgesia was maximal was approximately 45 min for bupivacaine and 30 min for amethocaine (table IV, fig. 1 ) (0.1 > P > 0.05).
Onset of motor blockade
Mean onset time to complete motor blockade was 8-9 min for both agents (table V, fig. 2 ).
Spread of sensory analgesia
The mean maximum spread of sensory analgesia was similar for both agents: T6-7 ( fig. 3) . Bupivacaine produced significantly (P < 0.05) higher cephalad spread of sensory analgesia than did amethocaine 180 min after injection ( fig. 3 ). 
Duration of sensory analgesia
The duration of sensory analgesia at L2 was around 4.5 and 3.5 h and at T10 around 3 and 2 h for the bupivacaine and amethocaine groups, respectively.
Significant differences were found between amethocaine and bupivacaine in the regression of analgesia from S5 (P < 0.05) to S3 (P < 0.05) and from L2 (P < 0.05) to T12 (P < 0.05) levels ( fig. 4) .
Duration of motor blockade
Motor blockade of the lower limbs was complete in nine of the 10 patients given bupivacaine and in seven of the 10 patients given amethocaine (table V) .
Duration of complete motor blockade of the lower limbs (degree 3) was approximately 3 h with amethocaine and 4.5 h with bupivacaine.
Significant differences were found for all degrees of motor blockade between amethocaine and bupivacaine (table V, fig. 5 ): degree 1, P < 0.01; degree 2, P < 0.001; degree 3, P < 0.01.
Quality of anaesthesia
Surgical anaesthesia was judged satisfactory in all patients.
Cardiovascular changes
The pre-anaesthetic arterial pressures and heart rates were comparable in the two groups. The mean decrease in systolic and diastolic arterial pressures was 10-15%. Heart rate decreased by 5-10%. Significant differences in changes in diastolic arterial pressure were found 10 min after the injection (P < 0.05). There were no significant differences in systolic arterial pressure or heart rate changes (figs 6, 7, 8) . Three patients given bupivacaine and three patients given amethocaine BRITISH JOURNAL OF ANAESTHESIA = 0.75% Bupivacaine; -= 0.5% amethocaine. received ephedrine because of hypotension. One patient given bupivacaine and two patients given amethocaine received atropine on account of bradycardia.
Adverse reactions
No patients developed postspinal headache.
DISCUSSION
This study was undertaken to examine the usefulness of 0.75 % bupivacaine and to compare it with the more widely used amethocaine. The durations of sensory analgesia and motor blockade were longer in the bupivacaine group, a difference which can be explained by the use of a larger dose of bupivacaine and the use of hyperbaric amethocaine in our study. Brown and colleagues (1980) found that duration of sensory analgesia was longer with isobaric than with hyperbaric amethocaine.
There was no significant difference in onset time to maximum spread of sensory analgesia, and the mean maximum spread was similar for both agents.
The onset time to complete motor blockade was similar for both agents, but motor blockade lasted significantly longer (for all degrees of motor blockade) in the bupivacaine group. Nine of the 10 patients receiving bupivacaine and seven of the 10 patients receiving amethocaine had complete motor blockade of the lower limbs. Once again, this difference may be attributable to the higher dose of bupivacaine.
By 10 min the diastolic arterial pressure had decreased significantly more in the hyperbaric amethocaine group than in the plain bupivacaine group. There were, however, no significant differences in systolic arterial pressure or in heart rate between the groups. Chambers, Edstrom and Scott (1981) noted that hyperbaric 0.5% bupivacaine decreased the diastolic arterial pressure significantly more than the plain solution.
Whether the hyperbaric solution can potentiate a greater sympathetic blockade because of the hyperosmolarity, and thus greater cardiovascular changes, needs further study.
It is concluded that 0.75% plain bupivacaine 3 ml is a good alternative to hyperbaric 0.5 % amethocaine with glucose in urological surgery of longer duration. The cardiovascular changes were less, and the durations of sensory analgesia and motor blockade were longer in the bupivacaine group.
